Company news

Beijing Balance Medical Technology Co. Ltd. Class A (SSE:688198) news

Beijing Balance Medical Technology Co. Ltd. Class A news releases on 6ix. Latest, Sep 24, 2026: "Beijing Balance Medical Technology Co., Ltd."Announcement…

Beijing Balance Medical Technology Co. Ltd. Class A (SSE:688198) news

Press releases & updates

"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure of the Approval for Registration of the Innovative Product, Valved Patch for Complex Congenital Heart Disease

"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure of the Aortic Root Enlargement Patch Entering the Special Review Procedure for Innovative Medical Devices

"Beijing Balance Medical Technology Co., Ltd."Announcement on Voluntary Disclosure of the Failure to Obtain Approval for the Registration Application for Ophthalmic Surgical Biological Patch

"Beijing Balance Medical Technology Co., Ltd."Semi-annual Report for 2026

"Beijing Balance Medical Technology Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing

"Beijing Balance Medical Technology Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction

"Beijing Balance Medical Technology Co., Ltd."Announcement on the Voluntary Disclosure of the Approval for Registration of the Subsidiary's Cross-Linked Collagen Implant Product (Collagen Fiber Filler-II)

"Beijing Balance Medical Technology Co., Ltd."Announcement on Canceling Certain Restricted Stock Granted but Not Yet Vested for 2020

"Beijing Balance Medical Technology Co., Ltd."Announcement on the Opening of an Additional Securities Account for Share Repurchase

"Beijing Balance Medical Technology Co., Ltd."Announcement on Increasing Sources of Funds for Share Repurchase and Receiving Commitment Letter for Special Loan for Share Repurchase

"Beijing Balance Medical Technology Co.,Ltd."Announcement on Progress in Repurchasing Shares through Call Auction

Announcement on Voluntary Disclosure of the Registration Approval of the Anastomotic Reinforcement and Repair Patch (Biological Patch for Digestive Surgery) Product

Announcement on Initially Repurchasing the Company's Shares through Call Auction

Announcement on Shareholding of Top 10 Shareholders and Top 10 Holders of Shares Without Sales Limit Concerning Shares Repurchase

Scheme for Repurchasing Shares through Call Auction

Announcement on Implementation of Dividend Distribution for 2025

Announcement on Resolutions of the 2025 Annual General Meeting

Announcement on the Resignation of Core Technical Personnel

Notice on Convening the 2025 Annual General Meeting

Announcement on Preliminary Earnings Estimate for 2025

Announcement on Voluntary Disclosure of the Approval and Registration of Subsidiary’s Collagen Implant Products

Announcement on the Voluntary Disclosure of ePTFE Pericardial Membrane Product Registration Approval

Report for Q3 2025

Announcement on Adjustment of Directors and Election of Employee Representative Directors for the 3rd Board of Directors

Announcement on Voluntary Disclosure of Entry of RF Ablation System into Special Review Procedure for Innovative Medical Devices

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

2025 Semi-annual Report

Announcement on Voluntary Disclosure of Acceptance of Registration Application for Patent Foramen Ovale Occluder

Announcement on Vesting Results of the 5th Vesting Period of Those Initially Granted and the 3rd Vesting Period of Those Reserved for Grant in 2020 Restricted Stock Incentive Plan and Listing of Shares

Announcement on Cancellation of Some 2020 Restricted Stocks Granted but Not Vested

Announcement on Voluntary Disclosure of Acceptance of Registration Application for Gastrointestinal Surgery Biological Mesh

Announcement on Implementation of Dividend Distribution for 2024

Announcement on Resolution of the 2024 Annual General Meeting

Report for Q1 2025

Announcement on Progress in Bidding for Land Use Rights and Investing in Construction Projects

Announcement on Results of Share Increase by Controlling Shareholder and Actual Controller

Announcement on Voluntary Disclosure of the Acceptance of the Registration Application for the Interventional Pulmonary Valve and Delivery System

Announcement on Preliminary Earnings Estimate for 2024

Announcement on Proposing to Purchase Land Use Rights and Invest in Construction Projects

Announcement on Voluntary Disclosure of Interventional Pulmonary Valve and Delivery System Entering the Special Review Procedure for Innovative Medical Devices

Announcement on Voluntary Disclosure of Acceptance of Registration Application for Ophthalmological Biological Mesh

Announcement on Voluntary Disclosure of Acceptance of Registration Application for Pericardium

Announcement on Convening the Q3 2024 Performance Briefing

Announcement on Voluntary Disclosure of Acceptance of Registration Application for Collagen Fiber Filler-I

Announcement on Share Increase Plan for Controlling Shareholder and Actual Controller

Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024

Announcement on Voluntary Disclosure of Registration Approval for Innovative Product "Transcatheter Aortic Valve Replacement System"

Announcement on Changing Registered Capital, Amending the Articles of Association and Handling Industrial and Commercial Change Registration

Announcement on Voluntary Disclosure of Registration Approval of Heart Valve Biological Mesh

Announcement on Vesting Results and Share Listing for the Fourth Vesting Period of the Initial Grant and the Second Vesting Period of the Reserved Grant under the 2020 Restricted Stock Incentive Plan